Our CEO, Adam Bruce, will be attending BIO Europe Spring, March 18-20, Barcelona, Spain. Reach out to schedule a meeting and learn more about our groundbreaking drug candidate ILB®, targeted at improving outcomes for people suffering from otherwise untreatable progressive and disabling neurodegenerative diseases, including:  ✅ amyotrophic lateral sclerosis (ALS)✅

TikoMed’s Medical Director was invited to participate in the NEALS (Northeast ALS Consortium) Clinical Trials Workshop: ALS Clinical Trials of the Future. The meeting focused on ALS clinical trials and designing them for success. It included presentations and panel discussions on topics such as innovative digital assessments, ALS biomarkers, genetics,

LSX Nordic Congress is a biotech, healthtech and medtech congress that attracts life science and healthcare industry leaders with international investment and strategic partners. The Nordic Congress, together with Nasdaq as partners, aim is to promote growth, internationalisation and investment in Scandinavian life sciences. TikoMed attends the congress by CEO

Bio International attracts 15,000+ biotechnology and pharma leaders who come together for networking to discover new opportunities and promising partnerships. The Convention theme ‘LIMITLESS’ is a commitment to unlocking possibilities for members and attendees while paving the path to the future of the industry. Bio International in San Diego is

Europe’s premier international showcase for financial dealmakers and biopharma executives to meet rising biotechs. BioEquity Europe in Milan is a high-level partnering and investor event where European financial dealmakers, biopharma executives, pharmaceutical companies and investors meet. BioEquity Europe in Milan is the the 22nd, previously digitally due to Covid-19, and